Antimicrobial resistance is one of the biggest challenges facing the NHS. Part of the solution is education and improved prescribing by doctors. Janssen-Cilag sponsored a meeting in May 2009 in Glasgow focussing on doripenem, a new carbapenem. This report highlights the role of doripenem in health-care-associated infection control.